Prescription Drug Monitoring Programs and Neonatal Outcomes

Arbeitspapier

Over the last two decades, the number of delivering mothers using or dependent on opiates has increased dramatically, giving rise to a five-fold increase in the proportion of babies born with neonatal abstinence syndrome (NAS). First, the current study documents NAS trends in the United States and their substantial variation across states. Second, it explores the relationship, if any, between the adoption of prescription drug monitoring programs (PDMPs) and reductions in NAS incidence across the United States. We find that the introduction of operational PDMPs reduced NAS incidence in the United States by 10%. We also examined the effects on birth outcomes, infant mortality, and other pregnancy complications and find little evidence of any effect of PDMPs on birth weight, premature births, and infant mortality.

Object Details

• Language: Englisch

References and Relationships

• Bibliographic citation: Series: IZA Discussion Papers ; No. 12796

Classification and Topics

• Classification: Wirtschaft ; Health: General
• Subject: opioid crisis ; infant outcomes ; health policy ; United States

Contributors, Places and Time

• Event: Geistige Schöpfung
• (who): Gihleb, Rania ; Giuntella, Osea ; Zhang, Ning
• Event: Veröffentlichung
• (who): Institute of Labor Economics (IZA)
• (where): Bonn
• (when): 2019

Further information

• Handle: http://hdl.handle.net/10419/215192
• Last update: 10.03.2025, 11:44 AM CET